Centerbridge makes $300m pharmaceutical bet

The New York firm has invested in Remedi SeniorCare, a Sterling Partners portfolio company, on the heels of closing its latest fund at $4.25bn.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this